Pharma Reviews: Tide turns for pharma as US FDA concerns get addressed

In March, India's largest drug maker Sun Pharmaceutical informed about the FDA lifting ban on its Mohali plant, paving the way for resumption of ...
Read more: Tide turns for pharma as US FDA concerns get addressed